Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Immunomodulatory Functions of BTK Inhibition in the Central Nervous System. | J Inflamm Res | 2022 | 36452053 | PubTator, text mining | PubMed |
| A history of childhood maltreatment is associated with altered DNA methylation levels of DNA methyltransferase 1 in maternal but not neonatal mononuclear immune cells. | Front Psychiatry | 2022 | 36440389 | PubTator, text mining | PubMed |
| Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database. | Front Pharmacol | 2022 | 36438789 | PubTator, text mining | PubMed |
| Inflammatory Cytokines That Enhance Antigen Responsiveness of Naïve CD8+ T Lymphocytes Modulate Chromatin Accessibility of Genes Impacted by Antigen Stimulation. | Int J Mol Sci | 2022 | 36430600 | PubTator, text mining | PubMed |
| Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma. | Cancers (Basel) | 2022 | 36428791 | PubTator, text mining | PubMed |
| EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3). | Cancers (Basel) | 2022 | 36428688 | PubTator, text mining | PubMed |
| Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland. | Biomedicines | 2022 | 36428480 | PubTator, text mining | PubMed |
| Strategies to enhance CAR-T persistence. | Biomark Res | 2022 | 36419115 | PubTator, text mining | PubMed |
| Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors. | ACS Pharmacol Transl Sci | 2022 | 36407952 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals TCR+ macrophages in HPV-related head and neck squamous cell carcinoma. | Front Immunol | 2022 | 36389736 | PubTator, text mining | PubMed |
| The types of tumor infiltrating lymphocytes are valuable for the diagnosis and prognosis of breast cancer. | Front Genet | 2022 | 36386851 | PubTator, text mining | PubMed |
| Tetrabromobisphenol A effects on differentiating mouse embryonic stem cells reveals unexpected impact on immune system. | Front Genet | 2022 | 36386828 | PubTator, text mining | PubMed |
| Screening Key lncRNAs of Ankylosing Spondylitis Using Bioinformatics Analysis. | J Inflamm Res | 2022 | 36386591 | PubTator, text mining | PubMed |
| Deregulated Expression of Circular RNAs Is Associated with Immune Evasion and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. | Genes (Basel) | 2022 | 36360223 | PubTator, text mining | PubMed |
| Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels. | Cancers (Basel) | 2022 | 36358737 | PubTator, text mining | PubMed |
| Reproducibility and repeatability of a semi-automated pipeline to quantify trapeziometacarpal joint angles using dynamic computed tomography. | BMC Med Imaging | 2022 | 36348287 | PubTator, text mining | PubMed |
| High-resolution cortical parcellation based on conserved brain landmarks for localization of multimodal data to the nearest centimeter. | Sci Rep | 2022 | 36335146 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. | Blood Cancer J | 2022 | 36329027 | PubTator, text mining | PubMed |
| Editorial: The cytoskeleton in T cell migration and activation. | Front Immunol | 2022 | 36311712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=25